Literature DB >> 19131646

ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells.

Yuepeng Wang1, Xiaoyu Rayne Zheng, Nadeene Riddick, Meredith Bryden, Wendy Baur, Xin Zhang, Howard K Surks.   

Abstract

Abnormal vascular smooth muscle cell (VSMC) contraction plays an important role in vascular diseases. The RhoA/ROCK signaling pathway is now well recognized to mediate vascular smooth muscle contraction in response to vasoconstrictors by inhibiting myosin phosphatase (MLCP) activity and increasing myosin light chain phosphorylation. Two ROCK isoforms, ROCK1 and ROCK2, are expressed in many tissues, yet the isoform-specific roles of ROCK1 and ROCK2 in vascular smooth muscle and the mechanism of ROCK-mediated regulation of MLCP are not well understood. In this study, ROCK2, but not ROCK1, bound directly to the myosin binding subunit of MLCP, yet both ROCK isoforms regulated MLCP and myosin light chain phosphorylation. Despite that both ROCK1 and ROCK2 regulated MLCP, the ROCK isoforms had distinct and opposing effects on VSMC morphology and ROCK2, but not ROCK1, had a predominant role in VSMC contractility. These data support that although the ROCK isoforms both regulate MLCP and myosin light chain phosphorylation through different mechanisms, they have distinct roles in VSMC function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131646      PMCID: PMC2649695          DOI: 10.1161/CIRCRESAHA.108.188524

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  42 in total

1.  p116Rip targets myosin phosphatase to the actin cytoskeleton and is essential for RhoA/ROCK-regulated neuritogenesis.

Authors:  Jacqueline Mulder; Aafke Ariaens; Dick van den Boomen; Wouter H Moolenaar
Journal:  Mol Biol Cell       Date:  2004-10-06       Impact factor: 4.138

2.  p116Rip decreases myosin II phosphorylation by activating myosin light chain phosphatase and by inactivating RhoA.

Authors:  Yasuhiko Koga; Mitsuo Ikebe
Journal:  J Biol Chem       Date:  2004-11-14       Impact factor: 5.157

3.  Cyclic GMP causes Ca2+ desensitization in vascular smooth muscle by activating the myosin light chain phosphatase.

Authors:  M R Lee; L Li; T Kitazawa
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

4.  p160ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions.

Authors:  T Ishizaki; M Naito; K Fujisawa; M Maekawa; N Watanabe; Y Saito; S Narumiya
Journal:  FEBS Lett       Date:  1997-03-10       Impact factor: 4.124

5.  ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice.

Authors:  O Nakagawa; K Fujisawa; T Ishizaki; Y Saito; K Nakao; S Narumiya
Journal:  FEBS Lett       Date:  1996-08-26       Impact factor: 4.124

6.  Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)

Authors:  K Kimura; M Ito; M Amano; K Chihara; Y Fukata; M Nakafuku; B Yamamori; J Feng; T Nakano; K Okawa; A Iwamatsu; K Kaibuchi
Journal:  Science       Date:  1996-07-12       Impact factor: 47.728

7.  Force mapping in epithelial cell migration.

Authors:  Olivia du Roure; Alexandre Saez; Axel Buguin; Robert H Austin; Philippe Chavrier; Pascal Silberzan; Pascal Siberzan; Benoit Ladoux
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-04       Impact factor: 11.205

8.  Targeting by myosin phosphatase-RhoA interacting protein mediates RhoA/ROCK regulation of myosin phosphatase.

Authors:  Nadeene Riddick; Ken-Ichi Ohtani; Howard K Surks
Journal:  J Cell Biochem       Date:  2008-03-01       Impact factor: 4.429

9.  Cyclic GMP-dependent stimulation reverses G-protein-coupled inhibition of smooth muscle myosin light chain phosphate.

Authors:  X Wu; A V Somlyo; A P Somlyo
Journal:  Biochem Biophys Res Commun       Date:  1996-03-27       Impact factor: 3.575

10.  The Rho kinases I and II regulate different aspects of myosin II activity.

Authors:  Atsuko Yoneda; Hinke A B Multhaupt; John R Couchman
Journal:  J Cell Biol       Date:  2005-07-25       Impact factor: 10.539

View more
  107 in total

Review 1.  Molecular pathophysiology of priapism: emerging targets.

Authors:  Uzoma A Anele; Belinda F Morrison; Arthur L Burnett
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  Attenuated RhoA/Rho-kinase signaling in penis of transgenic sickle cell mice.

Authors:  Trinity J Bivalacqua; Ashley E Ross; Travis D Strong; Milena A Gebska; Biljana Musicki; Hunter C Champion; Arthur L Burnett
Journal:  Urology       Date:  2010-06-09       Impact factor: 2.649

Review 3.  Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.

Authors:  Jeffrey A Beamish; Ping He; Kandice Kottke-Marchant; Roger E Marchant
Journal:  Tissue Eng Part B Rev       Date:  2010-10       Impact factor: 6.389

4.  Mechanisms underlying potentiation of endothelin-1-induced myofilament Ca(2+) sensitization after subarachnoid hemorrhage.

Authors:  Yuichiro Kikkawa; Satoshi Matsuo; Katsuharu Kameda; Mayumi Hirano; Akira Nakamizo; Tomio Sasaki; Katsuya Hirano
Journal:  J Cereb Blood Flow Metab       Date:  2011-09-28       Impact factor: 6.200

5.  Heterogeneous Impact of ROCK2 on Carotid and Cerebrovascular Function.

Authors:  T Michael De Silva; Dale A Kinzenbaw; Mary L Modrick; Lindsey D Reinhardt; Frank M Faraci
Journal:  Hypertension       Date:  2016-07-18       Impact factor: 10.190

6.  ROCK insufficiency attenuates ozone-induced airway hyperresponsiveness in mice.

Authors:  David I Kasahara; Joel A Mathews; Chan Y Park; Youngji Cho; Gabrielle Hunt; Allison P Wurmbrand; James K Liao; Stephanie A Shore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-08-14       Impact factor: 5.464

Review 7.  Role of rho kinase in the functional and dysfunctional tonic smooth muscles.

Authors:  Márcio A F de Godoy; Satish Rattan
Journal:  Trends Pharmacol Sci       Date:  2011-04-15       Impact factor: 14.819

Review 8.  Rho-kinase: regulation, (dys)function, and inhibition.

Authors:  Ehsan Amin; Badri Nath Dubey; Si-Cai Zhang; Lothar Gremer; Radovan Dvorsky; Jens M Moll; Mohamed S Taha; Luitgard Nagel-Steger; Roland P Piekorz; Avril V Somlyo; Mohammad R Ahmadian
Journal:  Biol Chem       Date:  2013-11       Impact factor: 3.915

Review 9.  Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.

Authors:  Jianjian Shi; Lei Wei
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

10.  Two functional polymorphisms of ROCK2 enhance arterial stiffening through inhibiting its activity and expression.

Authors:  Yi-Chu Liao; Ping-Yen Liu; Hsiu-Fen Lin; Wen-Yi Lin; James K Liao; Suh-Hang H Juo
Journal:  J Mol Cell Cardiol       Date:  2014-12-03       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.